Perceptive Life Sciences Master Fund, Director: Cerevel Therapeutics Holdings CERE Buy · Filed 23/10/17

Trade details

Type: Insider buy
Amount: $19,999,990.48
Shares · price: 876,808 sh · $22.81 a share
Held after: 10,794,876 sh
Stock: Cerevel Therapeutics Holdings CERE
Person: Perceptive Life Sciences Master FundDirector
Trade date: 23/10/16
Filed: 23/10/17
Days to filing: 1 days

10 insiders bought this week

Insiders buying this week: 10 insiders
Holding change: +8.8%

Cerevel Therapeutics Holdings trades, last 26 weeks

What else happened in Cerevel Therapeutics Holdings around then

Filed or reported within 30 days of the trade day · 23/09/16~23/11/15

Perceptive Life Sciences Master Fund's recent trades

Perceptive Life Sciences Master Fund10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$111.5K
28,597 sh
$111.5K
Filed 25/11/13
Traded 25/11/13
Perceptive Life Sciences Master Fund10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$31.9K
7,862 sh
$31.9K
Filed 25/11/13
Traded 25/11/12
Perceptive Life Sciences Master Fund10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$20.6K
4,783 sh
$20.6K
Filed 25/11/13
Traded 25/11/11
Perceptive Life Sciences Master Fund10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$12.5K
3,213 sh
$12.5K
Filed 25/11/13
Traded 25/11/13
Perceptive Life Sciences Master Fund10% Owner
SellLyra Therapeutics
Sell
Lyra Therapeutics
LYRA
$3,585
883 sh
$3,585
Filed 25/11/13
Traded 25/11/12

Perceptive Life Sciences Master Fund, Director — bought $20M of Cerevel Therapeutics Holdings CERE · 876,808 sh @ $22.81 | Whalegun